These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 2503025)

  • 41. Detection of lupus anticoagulant--an Australian perspective.
    Marshall LR
    Pathology; 1993 Oct; 25(4):360-2. PubMed ID: 8164999
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Regulation of coagulo-fibrinolytic activity and lupus anticoagulants in systemic lupus erythematosus].
    Fusegawa H; Ichikawa Y; Tanaka Y; Shiba T; Kawada T; Shimizu H; Moriuchi J; Arimori S; Ando Y
    Ryumachi; 1990 Apr; 30(2):90-8. PubMed ID: 2122531
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lupus anticoagulant. A report of 8 cases.
    Agarwal MB; Agarwal UM
    J Assoc Physicians India; 1991 Mar; 39(3):243-5. PubMed ID: 1908857
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Variability of cut-off values for the detection of lupus anticoagulants: results of an international multicenter multiplatform study.
    Tripodi A; Chantarangkul V; Cini M; Devreese K; Dlott JS; Giacomello R; Gray E; Legnani C; Martinuzzo ME; Pradella P; Siegemund A; Subramanian S; Suchon P; Testa S
    J Thromb Haemost; 2017 Jun; 15(6):1180-1190. PubMed ID: 28316135
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Lupus anticoagulant: an analysis of the clinical and laboratory features of 219 cases.
    Gastineau DA; Kazmier FJ; Nichols WL; Bowie EJ
    Am J Hematol; 1985 Jul; 19(3):265-75. PubMed ID: 3925759
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The laboratory heterogeneity of lupus anticoagulants.
    Triplett DA; Brandt JT; Maas RL
    Arch Pathol Lab Med; 1985 Oct; 109(10):946-51. PubMed ID: 3929747
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The lupus inhibitor in thromboembolic disease and intrauterine death in the absence of systemic lupus.
    Gårdlund B
    Acta Med Scand; 1984; 215(4):293-8. PubMed ID: 6428168
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Sensitivity of sixteen APTT reagents for the presence of lupus anticoagulants.
    Denis-Magdelaine A; Flahault A; Verdy E
    Haemostasis; 1995; 25(3):98-105. PubMed ID: 7607585
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Coagulation Testing in the Core Laboratory.
    Winter WE; Flax SD; Harris NS
    Lab Med; 2017 Nov; 48(4):295-313. PubMed ID: 29126301
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Lupus anticoagulant: performance of the tests as recommended by the latest ISTH guidelines.
    Swadzba J; Iwaniec T; Pulka M; De Laat B; De Groot PG; Musial J
    J Thromb Haemost; 2011 Sep; 9(9):1776-83. PubMed ID: 21707912
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evaluation of different mixing study reagents and dilution effect in lupus anticoagulant testing.
    Kaczor DA; Bickford NN; Triplett DA
    Am J Clin Pathol; 1991 Mar; 95(3):408-11. PubMed ID: 1899962
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Migraine and the lupus anticoagulant. Case reports and review of the literature.
    Levine SR; Joseph R; D'Andrea G; Welch KM
    Cephalalgia; 1987 Jun; 7(2):93-9. PubMed ID: 3111715
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of the lupus anticoagulant in patients with systemic lupus erythematosus on endothelial cell prostacyclin release and procoagulant activity.
    Rustin MH; Bull HA; Machin SJ; Isenberg DA; Snaith ML; Dowd PM
    J Invest Dermatol; 1988 May; 90(5):744-8. PubMed ID: 3129519
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Activated partial thromboplastin time derivative curves: helpful diagnostic tool in mixing test interpretation.
    Esmedere Eren S; Karakukcu C; Ciraci MZ; Ustundag Y; Karakukcu M
    Blood Coagul Fibrinolysis; 2018 Jun; 29(4):410-414. PubMed ID: 29708898
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical manifestations and laboratory findings in patients with lupus anticoagulants.
    Kornberg A; Silber L; Yona R; Kaufman S
    Eur J Haematol; 1989 Jan; 42(1):90-5. PubMed ID: 2914599
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Lupus anticoagulants in systemic lupus erythematosus: prevalence and clinical associations.
    Padmakumar K; Singh RR; Rai R; Malaviya AN; Saraya AK
    Ann Rheum Dis; 1990 Dec; 49(12):986-9. PubMed ID: 2125409
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lupus anticoagulant: a clinical and laboratory study of 100 cases.
    Jude B; Goudemand J; Dolle I; Caron C; Watel A; Tiry C; Cosson A
    Clin Lab Haematol; 1988; 10(1):41-51. PubMed ID: 3130214
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Detection of procoagulant phospholipid interfering in tests for lupus anticoagulant.
    Exner T; Low J
    Thromb Res; 2004; 114(5-6):547-52. PubMed ID: 15507290
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Presence of direct thrombin inhibitors can affect the results and interpretation of lupus anticoagulant testing.
    Genzen JR; Miller JL
    Am J Clin Pathol; 2005 Oct; 124(4):586-93. PubMed ID: 16146819
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Laboratory diagnosis of lupus inhibitors: a comparison of the tissue thromboplastin inhibition procedure with a new platelet neutralization procedure.
    Triplett DA; Brandt JT; Kaczor D; Schaeffer J
    Am J Clin Pathol; 1983 Jun; 79(6):678-82. PubMed ID: 6846258
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.